Office- versus home-based evaluation of quality of life in heart failure with reduced ejection fraction: A randomized study
Autores da FMUP
Participantes de fora da FMUP
- de Almeida Pinho I.
- Pimentel M.J.
- Oliveira C.
- Matos M.I.
- Vale C.
- Matias P.
- Pereira J.
- Marques P.
- Friões F.
- Vasques-Nóvoa F.
Unidades de investigação
Abstract
Background: Heart failure (HF) patients often experience poor health-related quality-of-life (HR-QoL). The Kansas City Cardiomyopathy Questionnaire (KCCQ) is frequently used for assessing HR-QoL in HF. Whether KCCQ scores vary in a clinical meaningful manner according to the setting (home vs office) where patients respond to the questionnaire is currently unknown. Aims: Assess the differences in the responses to KCCQ-23 questionnaire when completed at home or office. Methods: Randomized parallel-group study, including patients with HF with reduced ejection fraction (HFrEF). Primary outcome was home vs office comparison of overall summary score (KCCQ-OSS). Main secondary outcomes were clinical summary score (KCCQ-CSS) and total symptom score (KCCQ-TSS). Results: A total of 100 patients were included in the study: 50 home vs 50 office. Mean age was 71 yrs. Most baseline characteristics were well balanced between groups, except male sex, MRA use, and prior HF hospitalizations which were more frequent in the home group. No statistically-significant between-group differences were found regarding KCCQ-OSS (median [percentile25–75]) scores: home 69.1 (42.0–86.5) vs office 63.1 (44.3–82.3) points, P-value = 0.59, or main secondary outcomes: KCCQ-CSS home 62.2 (46.5–79.9) vs office 68.1 (51.9–79.2) points, P-value = 0.69, and KCCQ-TSS home 84.7 (59.7–97.2) vs office 76.4 (66.7–94.4) points, P-value = 0.85. Results remained similar after adjustment for differences in baseline characteristics and using non-parametric regressions. Conclusions: No major differences were found in KCCQ-23 scores regardless of whether the questionnaire was completed at home or office. These findings can be useful to make HR-QoL more accessible, allowing patients to respond at home using email or cell-phone applications. © 2024 Elsevier B.V.
Copyright © 2024 Elsevier B.V. All rights reserved.
Dados da publicação
- ISSN/ISSNe:
- 1874-1754, 0167-5273
- Tipo:
- Article
- Páginas:
- 132341-132341
- Link para outro recurso:
- www.scopus.com
International Journal of Cardiology Elsevier Ireland Ltd
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 1
Documentos
- Não há documentos
Filiações
Keywords
- Aged; Aged, 80 and over; Female; Heart Failure; Home Care Services; Humans; Male; Middle Aged; Office Visits; Quality of Life; Stroke Volume; Surveys and Questionnaires; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; sodium glucose cotransporter 2 inhibitor; acute heart failure; adult; aged; Article; atrial fibrillation; blood pressure; body mass; cardiogenic shock; chronic kidney failure; chronic obstructive lung disease; diabetes mellitus; diastolic blood pressure; echocardiography; electronic health record; female; health status; heart ejection fraction; heart failure with reduced ejection fraction; home; human; hypertension; hypoglycemia; kidney failure; major clinical study; male; middle aged; observational study; office versus Home; outcome assessment; proteinuria; quality of life; questionnaire; randomized controlled trial; scientific literature; six minute walk test; sleep apnea syndromes; social status; statistical analysis; systolic blood pressure;
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy Trial (STICH 3C) - NCT05427370
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (STICH 3C) . Cornell University . 2023
Initiation of ARNi and SGLT2i in Patients With HFrEF: Randomized Open-label Trial (INITIATE-HFrEF) -NCT05989503
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (INITIATE-HFrEF) . Novartis . 2023
Estudo do tratamento da doença valvular aórtica.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Observacional Académico (AORTA) . UniC . 2019
Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (Ensaio AGTP II) . 2019
Aortic valve surgery with stented versus stentless bioprosthesis in patients with active infective endocarditis
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Endocarditis) . 2023
Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Bypass) . 2020
Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Aortic Valve Replacemen) . 2020
Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
"Aortic valve surgery in patients with infective endocarditis: mid-term follow-up of patients treated with the St. Jude medical trifecta™ valve"
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2022
Long-term survival after coronary artery bypass grafting: the relevance of surgical procedures analysed by propensity score methods.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Arrtery bypass) . 2022
Abdominal Aortic Aneurysm - The Portuguese Case: Specificities and Consequences
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2022
New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Citar a publicação
de Almeida I,Pimentel MJ,Oliveira C,Matos MI,Vale C,Matias P,Pereira J,Marques P,Leite A,Friões F,Vasques F,Ferreira JP. Office- versus home-based evaluation of quality of life in heart failure with reduced ejection fraction: A randomized study. Int. J. Cardiol. 2024. 413. p. 132341-132341. IF:3,500. (2).